Acute citalopram administration may disrupt contextual information processing in healthy males

European Psychiatry

Volumn 25, Issue 2, 2010, Pages 87-91

  Almeida, S ^a   Glahn, D C ^b   Argyropoulos, S V ^a   Frangou, S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Institute of Living   (United Kingdom)

Author keywords

Antidepressant; Citalopram; Contextual processing; Response inhibition

Indexed keywords

CITALOPRAM; PLACEBO;

ADULT; AGITATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESEARCH; DRUG RESPONSE; DRUG WITHDRAWAL; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL PERFORMANCE; MENTAL TASK; METHODOLOGY; NORMAL HUMAN; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADOLESCENT; ADULT; CITALOPRAM; COGNITION; DOUBLE-BLIND METHOD; HUMANS; INHIBITION (PSYCHOLOGY); MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; RECOGNITION (PSYCHOLOGY); SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; YOUNG ADULT;

EID: 76349115589     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2009.05.010     Document Type: Article

References (28)

1. Aghajanian G, Sanders-Bush E. Serotonin. In: Davis K, Charney D, Coyle J, Nemeroff C, eds. Neuropsychopharmacology: The Fifth Generation of Progress: American College of Neuropsychopharmacology, Philadelphia Lippincott/Williams & Wilkins;2002.
2. Anderson I.M., Nutt D.J., and Deakin J.F. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. J Psychopharm 14 (2000) 3-20
3. Araneda R., and Andrade R. 5-Hydroxytryptamine 2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40 (1991) 399-412
4. Baldessarini R.J., Pompili M., and Tondo L. Suicidal risk in antidepressant drug trials. Arch Gen Psychiatry 63 (2006) 246-248
5. Baldwin D.S., Anderson I.M., Nutt D.J., Bandelow B., Bond A., Davidson J.R., et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharm 19 (2005) 567-596
6. Beck A.T., Epstein N., Brown G., and Steer R.A. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56 (1988) 893-897
7. Beck A.T., and Steer R.A. Beck Depression Inventory Manual San Antonio (1987), Harcourt Brace Jovanovic, Texas
8. Bersani G., Grispini A., Marini S., Pasini A., Valducci M., and Ciani N. 5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo. Clin Neuropharm 13 (1990) 500-506
9. Campbell S., Marriott M., Nahmias C., and MacQueen G.M. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry 161 (2004) 598-607
10. Cloninger C.R. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry 44 (1987) 573-588
11. Glahn D.C., Barrett J., Bearden C.E., Mintz J., Green M.F., Serap Monkul E., et al. Dissociable mechanisms for memory impairment in bipolar disorder and schizophrenia. Psychol Med 36 (2006) 1085-1095
12. Grunschlag C.R., Haas H.L., and Stevens D.R. 5-HT inhibits lateral entorhinal cortical neurons of the rat in vitro by activation of potassium channel-coupled 5-HT1A receptors. Brain Res 770 (1997) 10-17
13. Gunnell D., Saperia J., and Ashby D. Selective serotonin reuptake inhibitors (SSRI) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ 330 (2005) 385
14. Keilp J.G., Sackeim H.A., Brodsky B.S., Oquendo M.A., Malone K.M., and Mann J.J. Neuropsychological dysfunction in depressed suicide attempters. Am J Psychiatry 158 (2001) 735-741
15. Meltzer L.A., Yabaluri R., and Deisseroth K. A role for circuit homeostasis in adult neurogenesis. Trends Neurosci 28 (2005) 653-660
16. Naudon L., Hotte M., and Jay T.M. Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine. Psychopharmacology 191 (2007) 353-364
17. Nuechterlein KH, Asarnow RF. Degraded Stimulus Continuous Performance Test (DS-CPT): Program for IBM-Compatible Microcomputers. Version 8.11. Los Angeles CA;1999.
18. Nutt D.J. Death and dependence: current controversies over the selective serotonin reuptake inhibitors. J Psychopharm 17 (2003) 355-364
19. Oquendo M.A., Galfalvy H., Russo S., Ellis S.P., Grunebaum M.F., Burke A., et al. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry 161 (2004) 1433-1441
20. Patton J.H., Stanford M.S., and Barratt E.S. Factor structure of the Barratt impulsiveness scale. J Clinical Psychol 51 (1995) 768-774
21. Sánchez C., and Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 19 (1999) 467-489
22. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl. 20 (1998) 22-33
23. Spielberger C.D., Gorsuch R.L., Lushene R., Vagg P.R., and Jacobs G.A. Manual for the State-Trait Anxiety Inventory. Palo Alto (1983), Consulting Psychologists' Press, California
24. Stafford R., MacDonald E., and Finkelstein S. National patterns of medication treatment for depression, 1987 to 2001. Prim Care Companion J Clin Psychiatry 3 (2001) 232-235
25. Surget A., Saxe M., Leman S., Ibarguen-Vargas Y., Chalon S., Griebel G., et al. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol Psychiatry 64 (2008) 293-301
26. Swann A.C., Dougherty D.M., Pazzaglia P.J., Pham M., Steinberg J.L., and Moeller F.G. Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. Am J Psychiatry 162 (2005) 1680-1687
27. Winocur G., Wojtowicz J.M., Sekeres M., Snyder J.S., and Wang S. Inhibition of neurogenesis interferes with hippocampus-dependent memory function. Hippocampus 16 (2006) 296-304
28. Winsauer P.J., and Moerschbaecher J.M. Differential effects of 5-HT agonists and antagonists on the repeated acquisition and performance of response sequences in monkeys. Behav Pharmacol 11 (2000) 535-553